News Search

Category: Schools

I-Corps Participant and Vetigenics Founder Nicola Mason Featured on CBS 60 Minutes for Canine Cancer Research

Nicola Mason, BVetMed, PhD, of Penn Vet was featured on CBS' 60 Minutes, where she spoke about her research on immunotherapy treatment for cancer in dogs.

Penn Dental Medicine Study Finds That Cavity-causing Microbes Have the Ability to Form Superorgranisms that Can Crawl on Teeth

A Penn Dental Medicine study found that cavity-causing microbes have the ability to form superorgranisms that can sprout “limbs” that propel them to“leap” to quickly spread on the tooth surfaces.

Penn spinout Neuralert Technologies’ stroke detection wristband selected for TIME’s List of the Best Inventions of 2022

The lightweight, non-invasive wristband device can detect the stroke symptoms in as little as 15 minutes.

Emily Whitehead’s CAR-T Cell Therapy Journey Featured on CBS

CBS This Morning recently featured a story about Emily Whitehead, the first pediatric patient to receive Penn-invented CAR T cell therapy to fight cancer.

Drew Weismann Speaks on the Future of mRNA Technology in Bloomberg’s “The Big Take” Podcast

Weissman talks about his discovery and the impact of mRNA technology on the development of therapies for flu, cancer and rare genetic diseases.

Penn Dental Medicine Researchers Discover Potential Peripheral Nerve Injury Treatment

In their research, the team used SIS stem cells derived from gingival tissue to treat transected facial nerve and sciatic nerve crush injuries in rats.

PCI Team Member and Penn Medicine Featured in Washington Post

Carter Caldwell, Director of the Penn Medicine Co-Investment Program, was featured in the Washington Post’s Medical Mysteries column which described his journey following life-changing brain surgery.

Penn Medicine and Candel Therapeutics partner to pursue potential solid tumor CAR T-cell therapy

The University of Pennsylvania’s Center for Cellular Immunotherapies, led by cell therapy pioneer Dr. Carl June, has entered into a cancer treatment collaboration with Candel Therapeutics.

Weissman Lab is Working on New Type of Vaccines to Protect Against All Coronaviruses

The Weissman Lab is working towards developing vaccines that not only target multiple COVID variants, but also multiple types of coronaviruses.

Penn Engineering Commercialization Speaker Series

This fall, the Penn Center for Innovation and Penn Engineering present three monthly sessions with expert speakers, who will discuss funding, pitching, and open source software for commercialization.


Skip to content